Submission Details
| 510(k) Number | K041068 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 26, 2004 |
| Decision Date | October 20, 2004 |
| Days to Decision | 177 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K041068 is an FDA 510(k) clearance for the WEST NILE VIRUS IGG INDIRECT ELISA, a Elisa, Antibody, West Nile Virus (Class II — Special Controls, product code NOP), submitted by Panbio Limited (Windsor, AU). The FDA issued a Cleared decision on October 20, 2004, 177 days after receiving the submission on April 26, 2004. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3940.
| 510(k) Number | K041068 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 26, 2004 |
| Decision Date | October 20, 2004 |
| Days to Decision | 177 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | NOP — Elisa, Antibody, West Nile Virus |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3940 |
| Definition | The West Nile Virus Elisa Is Intended For The Detection Of Igg And Igm Antibodies To West Nile Virus. Specimens May Be Serum Or Cerebral Spinal Fluid From Symptomatic Patients. |